KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Debt to Equity (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Debt to Equity data on record, last reported at $0.59 in Q4 2025.

  • For Q4 2025, Debt to Equity rose 19.0% year-over-year to $0.59; the TTM value through Dec 2025 reached $0.59, up 19.0%, while the annual FY2025 figure was $0.59, 19.0% up from the prior year.
  • Debt to Equity reached $0.59 in Q4 2025 per ZBH's latest filing, down from $0.64 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.64 in Q3 2025 and bottomed at $0.02 in Q1 2021.
  • Average Debt to Equity over 5 years is $0.5, with a median of $0.5 recorded in 2024.
  • Peak YoY movement for Debt to Equity: tumbled 97.01% in 2021, then skyrocketed 2052.87% in 2022.
  • A 5-year view of Debt to Equity shows it stood at $0.56 in 2021, then fell by 15.13% to $0.47 in 2022, then decreased by 2.49% to $0.46 in 2023, then rose by 7.67% to $0.5 in 2024, then increased by 19.0% to $0.59 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt to Equity were $0.59 in Q4 2025, $0.64 in Q3 2025, and $0.6 in Q2 2025.